These Healthcare stocks are trading higher:
-Clarus Therapeutics Holdings Inc (CRXT) stock is trading at $5.56, an increase of $1.46, or 35.61%, on high volume. Clarus Therapeutics Hldgs Inc gets a Sentiment Score of Very Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $14.25.
-Sesen Bio Inc (SESN) stock is trading at $1.01, a gain of $0.18, or 20.86%, on moderate volume. Sesen Bio Inc gets a Sentiment Score of Very Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $4.25. Sesen Bio Inc next reports earnings on November 7.
-Orphazyme A/S (ORPH) stock is trading at $4.74, a gain of $0.76, or 19.1%, on high volume. Orphazyme A/S ADR gets a Sentiment Score of Bearish from InvestorsObserver and receives an average analyst recommendation of Hold with a price target of $1.00.
-Oncology Pharma Inc (ONPH) stock is trading at $9.18, a gain of $1.44, or 18.6%, on average volume. Oncology Pharma Inc gets a Sentiment Score of Bearish from InvestorsObserver.
Find the top stocks in the Healthcare Sector here.
These Healthcare stocks are trading lower:
-Neuroone Medical Technologies Corp (NMTC) stock is trading at $3.00, a loss of $1.12, or 28.16%, on high volume. Neuroone Medical Technologies Co gets a Sentiment Score of Neutral from InvestorsObserver.-Ardelyx Inc (ARDX) stock is trading at $1.08, a decline of $0.24, or 18.56%, on high volume. Ardelyx Inc gets a Sentiment Score of Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $5.75. Ardelyx Inc next reports earnings on November 11.
-Rezolute Inc (RZLT) stock is trading at $6.30, a drop of $1.31, or 17.87%, on high volume. Rezolute Inc gets a Sentiment Score of Very Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $24.25.
-Neuronetics Inc (STIM) stock is trading at $5.35, a decline of $1.05, or 16.41%, on high volume. Neuronetics Inc gets a Sentiment Score of Neutral from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $10.00. Neuronetics Inc next reports earnings on November 1.
